Trial Profile

An Open-Label, Multicenter, Extension Study of AG-348 in Adult Subjects With Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mitapivat (Primary)
Indications Pyruvate kinase deficiency of red cells
Focus Adverse reactions
Sponsors Agios Pharmaceuticals

Most Recent Events

11 Jul 2024 Status changed from active, no longer recruiting to completed.
05 Jul 2024 This trial has been completed in the France, According to European Clinical Trials Database record.
01 Jun 2024 This trial has been completed in the Netherlands.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com